Endoscopic Evaluation and Management of Cholangiocarcinoma.

Rohit Das, Aatur D Singhi, Adam Slivka

Journal: Gastroenterology clinics of North America 2022;51(3):519-535

PMID: 36153108

Full Text on Elsevier Science View on PubMed

Abstract

Cholangiocarcinoma is a rare malignancy of the biliary tract with a relatively poor prognosis. As a gastroenterologist, our main role is to differentiate between benign and malignant biliary disease, help achieve a diagnosis, and palliate jaundice related to biliary obstruction. This article focuses on summarizing the various tools currently available for endoscopic evaluation and management of cholangiocarcinoma.

Address: Division of Gastroenterology, Hepatology and Nutrition, UPMC Presbyterian, 200 Lothrop Street, Pittsburgh, PA 15213, USA.; UPMC Presbyterian, Department of Pathology, 200 Lothrop Street, Pittsburgh, PA 15213, USA.; Division of Gastroenterology, Hepatology and Nutrition, UPMC Presbyterian, 200 Lothrop Street, Pittsburgh, PA 15213, USA. Electronic address: [email protected].

DOI: 10.1016/j.gtc.2022.06.003

Link outs

Free resources

Medical:

https://medlineplus.gov/bileductcancer.html

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-HLA-B-1

Subscription / membership required

Full Text Sources:

MeSH Terms: Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cholangiocarcinoma, Cholangiopancreatography, Endoscopic Retrograde, Cholestasis, Humans